Thursday, June 3, 2021

Glenmark Pharma receives USFDA approval for Theophylline Extended-Release Tablets

Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity on the 450 mg.

from India Infoline News Service https://ift.tt/3vVpdPW
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)